Lon S. S. Schneider

机构：University of Southern California, Alzheimer’s Disease Neuroimaging Initiative · ORCID：0000-0002-4636-6150

发表论文 532 篇 · 总被引 60734 次 · h-index 88

代表论文

• Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024 · The Lancet · 被引 3664)
• Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer’s disease (2025 · Acta Neuropathologica Communications · 被引 30)
• Beyond symptom improvement: transdiagnostic and disorder‐specific ways to assess functional and quality of life outcomes across mental disorders in adults (2025 · World Psychiatry · 被引 25)
• Enhancing cognitive performance prediction by white matter hyperintensity connectivity assessment (2024 · Brain · 被引 21)
• The science does not yet support regulatory approval of amyloid‐targeting therapies for Alzheimer's disease based solely on biomarker evidence (2025 · Alzheimer s & Dementia · 被引 18)
• Escitalopram for agitation in Alzheimer’s dementia: a randomized controlled phase 3 trial (2025 · Nature Medicine · 被引 15)